Celularity
CELU
64 hedge funds and large institutions have $166M invested in Celularity in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 7 increasing their positions, 25 reducing their positions, and 14 closing their positions.
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
16% more funds holding
Funds holding: 55 → 64 (+9)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.1% less ownership
Funds ownership: 6.38% → 5.28% (-1.1%)
10% less capital invested
Capital invested by funds: $184M → $166M (-$18.6M)
72% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 25
Top Buyers
Top Sellers
CELU Hedge Fund Activity: Q4 2020 in Review
64 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q4 2020, worth a combined $166M — down 10% from $184M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CELU positions and 14 closed out — a net gain of 10 holders — while 7 added to existing stakes and 25 trimmed.
The largest buyer was BlueCrest Capital Management, opening a new position worth an estimated $14M. The largest seller was Polar Asset Management Partners, cutting an estimated $12.5M.
- 64 institutional investors held Celularity (CELU) as of Q4 2020, up from 55 in Q3 2020.
- Funds reported $166M of Celularity stock for Q4 2020, down 10% quarter-over-quarter.
- 24 funds opened new Celularity positions in Q4 2020 and 14 closed out, a net change of +10 holders.
- The largest Celularity buyer in Q4 2020 was BlueCrest Capital Management, an estimated $14M added.
- The largest Celularity seller in Q4 2020 was Polar Asset Management Partners, an estimated $12.5M sold.
Based on aggregated 13F filings for Q4 2020.